List of Tables
    Table 1. Cell-Based Immunotherapy Market Opportunities & Trends in Global Market
    Table 2. Cell-Based Immunotherapy Market Drivers in Global Market
    Table 3. Cell-Based Immunotherapy Market Restraints in Global Market
    Table 4. Key Players of Cell-Based Immunotherapy in Global Market
    Table 5. Top Cell-Based Immunotherapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Cell-Based Immunotherapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Cell-Based Immunotherapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Cell-Based Immunotherapy Product Type
    Table 9. List of Global Tier 1 Cell-Based Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cell-Based Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Cell-Based Immunotherapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Cell-Based Immunotherapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Cell-Based Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Cell-Based Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Cell-Based Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Cell-Based Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Cell-Based Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 30. Novartis Corporate Summary
    Table 31. Novartis Cell-Based Immunotherapy Product Offerings
    Table 32. Novartis Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 33. Gilead Sciences Corporate Summary
    Table 34. Gilead Sciences Cell-Based Immunotherapy Product Offerings
    Table 35. Gilead Sciences Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 36. AbbVie Corporate Summary
    Table 37. AbbVie Cell-Based Immunotherapy Product Offerings
    Table 38. AbbVie Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 39. Bristol-Myers Squibb Corporate Summary
    Table 40. Bristol-Myers Squibb Cell-Based Immunotherapy Product Offerings
    Table 41. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 42. Amgen Corporate Summary
    Table 43. Amgen Cell-Based Immunotherapy Product Offerings
    Table 44. Amgen Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 45. AstraZeneca Corporate Summary
    Table 46. AstraZeneca Cell-Based Immunotherapy Product Offerings
    Table 47. AstraZeneca Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 48. Biogen Corporate Summary
    Table 49. Biogen Cell-Based Immunotherapy Product Offerings
    Table 50. Biogen Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 51. Boehringer Ingelheim Corporate Summary
    Table 52. Boehringer Ingelheim Cell-Based Immunotherapy Product Offerings
    Table 53. Boehringer Ingelheim Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 54. Eli Lilly and Company Corporate Summary
    Table 55. Eli Lilly and Company Cell-Based Immunotherapy Product Offerings
    Table 56. Eli Lilly and Company Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 57. GSK Corporate Summary
    Table 58. GSK Cell-Based Immunotherapy Product Offerings
    Table 59. GSK Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 60. Pfizer Corporate Summary
    Table 61. Pfizer Cell-Based Immunotherapy Product Offerings
    Table 62. Pfizer Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 63. Roche Corporate Summary
    Table 64. Roche Cell-Based Immunotherapy Product Offerings
    Table 65. Roche Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 66. Takara Bio Corporate Summary
    Table 67. Takara Bio Cell-Based Immunotherapy Product Offerings
    Table 68. Takara Bio Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 69. Bausch Health Corporate Summary
    Table 70. Bausch Health Cell-Based Immunotherapy Product Offerings
    Table 71. Bausch Health Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 72. Apac Biotech Corporate Summary
    Table 73. Apac Biotech Cell-Based Immunotherapy Product Offerings
    Table 74. Apac Biotech Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 75. Dendreon Pharmaceuticals (SanPower) Corporate Summary
    Table 76. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Offerings
    Table 77. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 78. JW CreaGene Corporate Summary
    Table 79. JW CreaGene Cell-Based Immunotherapy Product Offerings
    Table 80. JW CreaGene Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 81. Green Cross Corp Corporate Summary
    Table 82. Green Cross Corp Cell-Based Immunotherapy Product Offerings
    Table 83. Green Cross Corp Cell-Based Immunotherapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Cell-Based Immunotherapy Segment by Type in 2021
    Figure 2. Cell-Based Immunotherapy Segment by Application in 2021
    Figure 3. Global Cell-Based Immunotherapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cell-Based Immunotherapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cell-Based Immunotherapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2021
    Figure 8. By Type - Global Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 12. US Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 16. Germany Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 24. China Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Cell-Based Immunotherapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Cell-Based Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Novartis Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Gilead Sciences Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. AbbVie Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Amgen Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AstraZeneca Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Biogen Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Boehringer Ingelheim Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Eli Lilly and Company Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. GSK Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Pfizer Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Roche Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Takara Bio Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Bausch Health Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Apac Biotech Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. JW CreaGene Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Green Cross Corp Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)